Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people who’ve been there
  • People who understand what you’re going through
Sign Up Log In
Powered By

How Long Can You Live With Proteinuria? Understanding Outlook and Treatment

Medically reviewed by Walead Latif, D.O.
Written by Sarah Winfrey
Updated on September 8, 2026

Key Takeaways

  • Finding protein in your urine, known as proteinuria, can feel scary, but it does not automatically predict how long you will live or mean your health will get worse.
  • View all takeaways

Finding protein in your urine, called proteinuria, can be worrying, especially if you have IgA nephropathy (IgAN) or another type of chronic kidney disease. Proteinuria that involves a protein called albumin is known as albuminuria.

Proteinuria does not predict how long you’ll live, but it can offer important clues about your kidney health and your risk of future problems. Here’s what proteinuria may mean for your outlook, what can affect your risk, and how treatment may help protect your kidneys over time.

Proteinuria and Life Expectancy

There is no set life expectancy for someone with proteinuria. People can live for many years with protein in their urine, especially when the cause is treated and their kidney function stays stable. Proteinuria does not automatically mean you’ll live a shorter life, but it can be a sign that your kidneys are under stress or damaged and that you have a higher risk of kidney and heart problems.

🗳️ Have you tried lifestyle changes to help manage proteinuria or support kidney health?
Yes, and it helped.
Yes, but it didn’t help.
No, but I’m interested.
No, and I’m not interested.

How proteinuria affects your outlook depends on factors like how much protein is in your urine, how well your kidneys are working, and how quickly kidney function is changing. In general, higher or long-lasting proteinuria is linked with faster loss of kidney function. If IgA nephropathy or another kidney condition is causing proteinuria, regular monitoring and treatment can help protect your kidneys over time.

Proteinuria Factors That Influence Kidney Damage and Function

The kidneys have tiny filters called glomeruli. When these filters are damaged, a protein in the blood called albumin can leak into the urine. How much protein leaks out can offer clues about your kidney health.

Your nephrologist (a doctor who specializes in kidney diseases) will look at your proteinuria along with other test results to see how well your kidneys are working and whether your kidney function is staying stable.

Protein Levels and Blood Pressure

The amount of protein in your urine is one important factor. It can help doctors understand your risk of kidney disease getting worse over time. It’s important to remember that any life expectancy numbers you see are averages, not a prediction of exactly how long you’ll live.

For people with IgAN, the goal is to keep proteinuria below about 0.5 grams per day, and ideally below 0.3 grams per day. Even lower levels of long-term proteinuria can still carry some risk.

In addition, keeping your blood pressure under control can help your kidneys function better, even if you have long-term proteinuria. In fact, hypertension (high blood pressure) is common enough in people with kidney problems that some researchers have suggested lower life expectancies in people with proteinuria may be partially caused by high blood pressure, but this relationship is still being studied.

Kidney Function and eGFR

How quickly your kidney function is changing can also affect your overall outlook. In IgA nephropathy, people whose kidney function declines more slowly often have better long-term outcomes.

Treatments may take time to work. Starting the right treatment and taking it as prescribed may help protect your kidneys.

Finally, your doctor may also test your estimated glomerular filtration rate (eGFR). This number is calculated from a straightforward blood test that gives you and your nephrology team an estimate of how well your kidneys are filtering.

You can have proteinuria and a normal eGFR. However, people with a higher eGFR often have a better outlook overall, even if they have some protein in their urine.

Taking steps to protect your kidneys may help slow kidney disease and lower your risk of complications. Many people whose kidney problems, such as IgAN, are found early can live for many years, even if some protein remains in their urine.

Age, Sex, and Life Expectancy With Proteinuria

Your age and sex assigned at birth can play a role in how kidney disease progresses if you have proteinuria. These factors don’t determine how long you’ll live, but they may affect your overall outlook.

If your healthcare provider discusses proteinuria and your long-term outlook, ask whether the information is based on people with a similar profile and similar health conditions. This can help you get a clearer picture of what to expect and how to best protect your kidney health.

Treatments for Proteinuria

There are steps you can take to support your kidney health and help reduce the protein in your urine. Not every approach will be right for everyone. Your doctor can help you develop a treatment plan based on your kidney health and the cause of your proteinuria.

Lifestyle Changes

Certain lifestyle changes may help protect your kidneys. You may need to limit sodium, adjust how much protein you eat, or change how much potassium or phosphorus you get from food based on your lab results.

These changes can reduce the amount of waste and minerals your kidneys have to handle. A registered dietitian can help you build a balanced eating plan that fits your kidney needs and other conditions, such as diabetes or high blood pressure.

If you drink alcohol or use tobacco, your doctor may recommend cutting back or quitting. Regular exercise can also support kidney and heart health and may help with blood pressure, diabetes, mood, and weight. Talk with your doctor about what types of activity are safe for you and whether you need help from a physical therapist or other exercise professional.

Medications

There are medications that can help protect your kidneys and slow the loss of kidney function.

Medications That Protect Kidney Function

Angiotensin-converting enzyme (ACE) inhibitors and angiotensin-receptor blockers (ARBs) reduce the effects of a hormone called angiotensin-2. These medications help relax blood vessels and lower pressure in the kidneys, which can help protect kidney function and lower proteinuria. They are commonly used for several kidney diseases, including IgAN.

Medications called sodium-glucose cotransporter 2 (SGLT2) inhibitors may also help protect your kidneys and lower proteinuria. They help your body get rid of extra salt and sugar through the urine, which helps the filtering system in your kidneys work better. This lowers pressure in the kidneys’ filters, which can help slow kidney damage. They may be especially useful for people living with IgAN and proteinuria.

Medications called nonsteroidal mineralocorticoid receptor antagonists (nsMRAs) affect aldosterone, a hormone that helps control salt and fluid levels in the body. This allows the body to release more salt and water in urine, which lowers pressure in the kidneys’ filtering system.

Finerenone (Kerendia) is currently the only nsMRA available in the United States. It is approved by the U.S. Food and Drug Administration (FDA) for chronic kidney disease linked to type 2 diabetes, but not specifically for IgAN. Researchers are studying finerenone and other nsMRAs for people with IgAN and other types of kidney disease.

Medications That Target Inflammation or IgAN

If proteinuria is caused by certain autoimmune or inflammatory kidney diseases, your doctor may consider corticosteroids or other medications that suppress the immune system. Doctors consider these medications carefully because they can weaken the immune system and cause side effects.

In recent years, several new medications have received FDA approval for adults with primary IgAN who are at risk for disease progression. Some are approved because they lower proteinuria or slow the loss of kidney function:

  • Atacicept-vymj (Trutakna) works on two proteins involved in the immune system, B-cell activating factor and A proliferation-inducing ligand, to reduce proteinuria. It has FDA accelerated approval to reduce proteinuria, meaning it was approved based on evidence that it lowers proteinuria while studies continue to confirm its long-term effects on kidney function.
  • Atrasentan (Vanrafia) blocks a protein that can increase pressure in the kidneys’ filters, helping lower proteinuria. It has FDA accelerated approval to reduce proteinuria, but its long-term effects on kidney function are still being studied.
  • Budesonide (Tarpeyo) is a targeted-release steroid that reduces inflammation in the gut, which can decrease IgA production and lower proteinuria. It is approved to slow the decline of kidney function.
  • Iptacopan (Fabhalta) blocks part of the immune system that can become overactive in IgAN. It is approved to slow kidney function decline in adults with primary IgAN at risk of disease progression.
  • Sibeprenlimab-szsi (Voyxact) is an antibody that targets the IgA pathway and has accelerated approval from the FDA to reduce proteinuria in adults with primary IgAN. Its long-term effects on kidney function are still being studied.
  • Sparsentan (Filspari) blocks two pathways that can raise pressure in the kidneys’ filters, helping reduce proteinuria. It is approved to slow the decline of kidney function.

Medications that suppress the immune system are usually used only when IgAN is more likely to get worse. Treatment may also include blood pressure control, lifestyle changes, SGLT2 inhibitors, or medications that target IgAN directly, depending on your risk and kidney function.

Your doctor will help you choose the best medication or combination of medications based on your symptoms, kidney function, and overall health.

Join the Conversation

On myIgANteam, people share their experiences with IgAN, get advice, and find support from others who understand.

What treatment options have worked best to help you manage your proteinuria? Let others know in the comments below.

References
  1. Albuminuria (Proteinuria) — National Kidney Foundation
  2. Mortality Risk and Years of Life Lost for People With Reduced Renal Function Detected From Regular Health Checkup: A Matched Cohort Study — Preventive Medicine Reports
  3. Life Expectancy With Chronic Kidney Disease: An Educational Review — Pediatric Nephrology
  4. Proteinuria and Life Expectancy — American Journal of Kidney Diseases
  5. KDIGO’s New IgA Nephropathy Guideline Is Paradigm-Shifting — Renal + Urology News
  6. Long-Term Outcomes in IgA Nephropathy — Clinical Journal of the American Society of Nephrology
  7. Estimated Glomerular Filtration Rate (eGFR) — National Kidney Foundation
  8. Kidney Function, Albuminuria and Life Expectancy — Canadian Journal of Kidney Health and Disease
  9. Nutrition and Kidney Disease, Stages 1-5 (Not on Dialysis) — National Kidney Foundation
  10. Exercise and Chronic Kidney Disease — National Kidney Foundation
  11. ACE Inhibitors and ARBs — National Kidney Foundation
  12. SGLT2 Inhibitors — National Kidney Foundation
  13. Non-Steroidal MRAs — National Kidney Foundation
  14. Immunosuppressive Drugs for Renal Disease — Edinburgh Renal Unit
  15. IgA Nephropathy: What Is New in Treatment Options? — Kidney and Dialysis
  16. Novartis Receives FDA Accelerated Approval for Vanrafia (Atrasentan), the First and Only Selective Endothelin A Receptor Antagonist for Proteinuria Reduction in Primary IgA Nephropathy (IgAN) — Novartis
  17. FDA Approves First Drug To Decrease Urine Protein in IgA Nephropathy, a Rare Kidney Disease — U.S. Food and Drug Administration
  18. Filspari (Sparsentan) — Drugs.com
  19. Novartis Receives FDA Accelerated Approval for Fabhalta (Iptacopan), the First and Only Complement Inhibitor for the Reduction of Proteinuria in Primary IgA Nephropathy (IgAN) — Novartis
  20. Otsuka Receives FDA Accelerated Approval for Voyxact (Sibeprenlimab‑szsi) for Reduction of Proteinuria in Adults With Primary IgA Nephropathy (IgAN) at Risk for Disease Progression — Otsuka Pharmaceutical
  21. FDA Approves New Treatment To Reduce Proteinuria in Adults With Primary Immunoglobulin A Nephropathy — U.S. Food and Drug Administration
  22. Immunosuppression Versus Supportive Care on Kidney Outcomes in IgA Nephropathy in the Real-World Setting — Clinical Journal of the American Society of Nephrology
  23. Top 10 Takeaways From the KDIGO 2025 Clinical Practice Guideline for the Management of IgA Vasculitis (IgAV) — KDIGO
Share this article
All updates must be accompanied by text or a picture.

We'd love to hear from you! Please share your name and email to post and read comments.

You'll also get the latest articles directly to your inbox.

Subscriber Photo Subscriber Photo Subscriber Photo
15,631 members
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service.
Privacy Policy Terms of Use
All updates must be accompanied by text or a picture.

Subscribe now to ask your question, get answers, and stay up to date on the latest articles.

Get updates directly to your inbox.

Subscriber Photo Subscriber Photo Subscriber Photo
15,631 members
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service.
Privacy Policy Terms of Use
Continue with Facebook
Continue with Google
By joining, you accept our Terms of Use, and acknowledge our collection, sharing, and use of your data in accordance with our Health Data and Privacy policies.
Already a member? Log In

Thank you for subscribing!

Become a member to get even more

See answer